Otolaryngology Doctors in Layton, UT Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Robert L Mellor, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840    Fax: 801-525-8151

Dr. John B Bitner, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840    Fax: 801-525-8151

Bryan L Richards, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840    Fax: 801-525-8151

Tolbin Matthew Collett, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 201 W Layton Pkwy, Layton, UT 84041 Phone: 801-543-6900

Richard Van Leeuwen, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840    Fax: 801-525-8179

Bryan Kent Wilcox, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2132 N Robins Dr Ste 305, Layton, UT 84041 Phone: 801-776-2180    Fax: 801-776-2534

News Archive

DiaCarta raises $8 million in Series A financing from BVCF

DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.

Mayo Clinic research clarifies relationship between two genes that fuel neuroblastoma spread

For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas.

Widespread support for electronic cigarettes

Thousands and thousands have left tobacco for an alternative called an electronic cigarette, that is making waves in the news, government and the general population. The support is widespread and diverse, from prominent doctors and harm reduction specialists to the users and family members of the ones who are hoping against hope that this will be the product that can reduce the risk of traditional tobacco cigarettes.

IAS announces winners of awards recognizing HIV researchers to be presented during AIDS 2012

"The International AIDS Society (IAS) on Wednesday announced nine winners of four prestigious scientific awards to be presented during the XIX International AIDS Conference (AIDS 2012) to be held in Washington, D.C., 22–27 July," an IAS press release states.

New drug trial to target hereditary cancers

Cancer Research UK scientists at Newcastle University are starting the first UK trial of a new drug which targets the 'Achilles' heel' in hereditary forms of both breast and ovarian cancer.

Read more Medical News

› Verified 5 days ago